Intravitreal Bevacizumab as a Primary Treatment for Idiopathic Choroidal Neovascularization

PURPOSE: To report long-term outcomes of the use of intravitreal bevacizumab in subjects with idiopathic choroidal neovascularization (ICNV). MATERIALS AND METHODS: Six consecutive subjects with ICNV were included in this prospective study. All subjects received 1.25 mg intravitreal bevacizumab at d...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheema, Rizwan A., Mushtaq, Javed, Cheema, Maheera A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162734/
https://www.ncbi.nlm.nih.gov/pubmed/21887077
http://dx.doi.org/10.4103/0974-9233.84051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162734/
https://www.ncbi.nlm.nih.gov/pubmed/21887077
http://dx.doi.org/10.4103/0974-9233.84051

Ejemplares similares